ALZCUR.ST
AlzeCure Pharma AB (publ) [ALZCUR.ST] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
ALZCUR.ST Stock Summary
Top 10 Correlated Stocks
ALZCUR.ST
In the News
ALZCUR.ST Financial details
Company Rating
-
Market Cap
127.28M
Income
-36.95M
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
11
Optionable
No
Shortable
Yes
Earnings
02 May 2024
P/E
-5.06
Forward P/E
-
PEG
1.02
P/S
-
P/B
5.74
P/C
-
P/FCF
-4.84
Quick Ratio
5.46
Current Ratio
5.81
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.59
EPS next Y
-
EPS next Q
-
EPS this Y
-48.72%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
33.33%
-
-
-
-
SMA20
-13.37%
SMA50
21.79%
SMA100
147.83%
Inst Own
-
Inst Trans
-
ROA
-94%
ROE
-82%
ROC
-1.17%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1.595-6.54
52W High
-50.67%
52W Low
+196%
RSI
53.39
Rel Volume
2.11
Avg Volume
69.62K
Volume
147.17K
Perf Week
3.5%
Perf Month
10.45%
Perf Quarter
136.8%
Perf Half Y
94.74%
-
-
-
-
Beta
0.385
-
-
Volatility
0.18%, 0.34%
Prev Close
8.82%
Price
2.96
Change
17%
Company Profile
- Volume Average 69.62K
- Market Capitalization 127.28M
- Employee 11
- CEO Mr. Martin Jönsson
- Headquarters Huddinge,SE
- IPO Date 2018-11-28
-
Website
https://www.alzecurepharma.se 
AlzeCure Pharma AB (publ), a pharmaceutical company, develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system. The company is developing drug candidates based on the NeuroRestore, Alzstatin, and Painless research platforms. Its pipeline drug candidates include ACD856, which is in phase I clinical trial for Alzheimer's disease, sleep disorders, traumatic brain injuries, and Parkinson's disease; ACD857, ACD679, and ACD680 for Alzheimer's disease; ACD440, a TRPV1 antagonist that has completed phase I clinical trial for neuropathic pain; and TrkA-NAM for osteoarthritic pain. The company was founded in 2012 and is based in Huddinge, Sweden.
